PACS vs CON

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

PACS

32.9
AI Score
VS
CON Wins

CON

34.9
AI Score

Investment Advisor Scores

PACS

33score
Recommendation
AVOID NEW MONEY

CON

35score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric PACS CON Winner
Forward P/E 15.528 18.018 PACS
PEG Ratio 1.0347 0 Tie
Revenue Growth 9.1% 10.0% CON
Earnings Growth 51.6% 47.0% PACS
Tradestie Score 32.9/100 34.9/100 CON
Profit Margin 4.9% 8.7% CON
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY EXTENDED CON

Relative Price Performance (Last 90 Days)

PACS 1M: +12.6% · 3M: +4.3% CON 1M: +12.1% · 3M: +24.0%

Current Technical Phase

PACS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 61

RSI (14): 60.6 · Price: $46.76

CON

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.9% over 20 days), RSI 71

RSI (14): 70.9 · Price: $39.09

Fundamentals Snapshot

Metric PACS CON
Market Cap — —
Forward P/E 17.1 21.2
Trailing P/E 27.9 25.0
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.2% 0.3%
Operating Margin 0.1% 0.2%
EPS 1.71 1.55
Dividend Yield — 0.01%

Frequently Asked Questions

Based on our detailed analysis, CON is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.